Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: Evaluating the effects on outcome

European Journal of Pediatrics, Supplement

Volumn 162, Issue 1, 2003, Pages

  Dezateux, Carol ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Evaluation studies; Fatty acid desaturases deficiency genetics; Infant; Mass screening; Newborn; Population surveillance

Indexed keywords

MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

COGNITION; CONFERENCE PAPER; DIAGNOSTIC TEST; ENZYME DEFICIENCY; HEALTH CARE; HUMAN; INFORMATION PROCESSING; MEDICAL DECISION MAKING; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; NEWBORN SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; TANDEM MASS SPECTROMETRY; TASK PERFORMANCE;

EID: 0347320496     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1346-0     Document Type: Conference Paper

References (28)

1. Andresen BS, Dobrowolski SF, O'Reilly L, Muenzer J, McCandless SE, Frazier DM et al (2001) Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/ MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet 68: 1408-1418
2. Atkinson K, Zuckerman B, Sharfstein JM, Levin D, Blatt RJ, Koh HK (2001) A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep 116: 122-131
3. Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK et al (1998) Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 132: 924-933
4. Carpenter K, Wiley V, Sim KG, Heath D, Wilcken B (2001) Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275,000 babies. Arch Dis Child 85: F105-F109
5. Clayton PT, Doig M, Ghafari S, Meaney C, Taylor C, Leonard JV et al (1998) Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry. Arch Dis Child 79: 109-115
6. Dezateux C (1998) Evaluating newborn screening programmes based on dried blood spots: future challenges. Br Med Bull 54: 877-890
7. Dixon MA, Leonard JV (1992) Intercurrent illness in inborn errors of intermediary metabolism. Arch Dis Child 67: 1387-1391
8. Elliman D, Dezateux C, Bedford H (2002) Newborn and childhood screening programmes: criteria, evidence and current policy. Arch Dis Child 87: 6-9
9. Holtzman NA (1999) Are genetic tests adequately regulated? Science 286: 409
10. Iafolla AK, Thompson RJ, Roe CR (1994) Medium-chain-acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 124: 409-414
11. Kwon C, Farrell PM (2000) The magnitude and challenge of false-positive newborn screening test results. Arch Pediatr Adolesc Med 154: 714-718
12. Leonard JV, Dezateux C (2002) Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry. BMJ 324: 4-5
13. Liebl B, Fingerhut R. Roschinger W, Muntau A, Knerr I, Olgemoller B et al (2000) Model project for updating neonatal screening in Bavaria: concept and initial results. Gesundheitswesen 62: 189-195
14. Peckham CS, Dezateux C (1998) Issues underlying the evaluation of screening programmes. Br Med Bull 54: 767-778
15. Pollitt RJ, Leonard JV (1998) Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK. Arch Dis Child 79: 116-119
16. Pollitt RJ, Green A, McCabe ERB, Booth A, Cooper NJ (1997) Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technology Assessment 1: 1-202
17. Pourfarzam M, Morris A, Appleton M, Craft AW, Bartlett K (2001) Neonatal screening for MCAD deficiency: support from a retrospective study. Lancet 358: 1063-1064
18. Report of a Work Group (2001) Using tandem mass spectrometry for metabolic disease screening among newborns. Morb Mortal Weekly Report 50: 1-34
19. Seddon HR, Gray G, Pollitt RJ, Iitia A, Green A (1997) Population screening for the common G985 mutation causing medium-chain acyl-CoA dehydrogenase deficiency with Eu-labeled oligonucleotides and the DELFIA system. Clin Chem 43: 436-442
20. Seymour CA, Chalmers RA, Addison GM, Bain MD, Cockbern F, Littlejohns P et al (1997) Neonatal screening for inborn errors of metabolism: a systematic review. Health Technology Assessment 1: 1-95
21. Simonsen H, Jensen UG, Brandt NJ, Christensen E, Skovby F, Norgaard-Pedersen B (1999) Design of a pilot study to evaluate tandem mass spectrometry for neonatal screening. Southeast Asian J Trop Med Public Health 30[Suppl 2]: 166-169
22. Wald NJ (1994) Guidance on terminology. J Med Scr 1: 76
23. Wang SS, Fernhoff PM, Hannon WH, Khoury MJ (1999) Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med 1: 332-339
24. Wang SS, Fernhoff PM, Khoury MJ (2000) Is the G985A allelic variant of medium-chain acyl-CoA dehydrogenase a risk factor for sudden infant death syndrome? A pooled analysis. Pediatrics 105: 1175-1176
25. Wilcken B (2001) Rare disease and the assessment of intervention: what sorts of clinical trials can we use? J Inherit Metab Dis 24: 291-298
26. Wilcken B, Hammond J, Silink M (1994) Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency. Arch Dis Child 70: 410-412
27. Wilson CJ, Champion MP, Collins JE, Clayton PT, Leonard JV (1999) Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis. Arch Dis Child 80: 459-462
28. Ziadeh R, Huffman EP, Finegold DN, Hoop RC, Brackett JC, Strauss AW et al (1995) Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 37: 675-678